These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 5095412)

  • 81. Gonadectomy and sex differences in the behavioral responses to amphetamine and apomorphine of rats.
    Savageau MM; Beatty WW
    Pharmacol Biochem Behav; 1981 Jan; 14(1):17-21. PubMed ID: 7193328
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Ontogeny of stereotyped behaviour induced by apomorphine and amphetamine in the rat.
    Lal S; Sourkes TL
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):171-82. PubMed ID: 4694351
    [No Abstract]   [Full Text] [Related]  

  • 83. On the mode of action of apomorphine.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1973 Mar; 21(3):350-61. PubMed ID: 4708071
    [No Abstract]   [Full Text] [Related]  

  • 84. [Aggressiveness of the rat following combined treatment with monomaime oxidase inhibitors and other psychotropic drugs, especially thymoleptics].
    Zetler G; Otten U
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(1):32-54. PubMed ID: 4390354
    [No Abstract]   [Full Text] [Related]  

  • 85. Influence of estrogen and progesterone on behavioral effects of apomorphine and amphetamine.
    Michanek A; Meyerson BJ
    Pharmacol Biochem Behav; 1982 Jun; 16(6):875-9. PubMed ID: 7202216
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Troncone LR; Ferreira TM; Braz S; Silveira Filho NG; Tufik S
    Psychopharmacology (Berl); 1988; 94(1):79-83. PubMed ID: 3126531
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Effects of psychotropic drugs on hypothalamic self-stimulation behavior in rats.
    Kamei C; Masuda Y; Shimizu M
    Jpn J Pharmacol; 1974 Aug; 24(4):613-9. PubMed ID: 4455970
    [No Abstract]   [Full Text] [Related]  

  • 88. Behavioral effects of amfonelic acid in rats: a comparison with amphetamine and apomorphine.
    Jeste DV; Perlow MJ; Wyatt RJ; Stoff DM
    Commun Psychopharmacol; 1979; 3(1):41-7. PubMed ID: 38031
    [No Abstract]   [Full Text] [Related]  

  • 89. Blocking H 3 -Norepinephrine uptake and some guanethidine-induced effects with tricyclic psychotherapeutic drugs.
    Koe BK; Constantine JW
    Arch Int Pharmacodyn Ther; 1972 Jan; 195(1):71-80. PubMed ID: 5010834
    [No Abstract]   [Full Text] [Related]  

  • 90. Reactions to apomorphine and spiroperidol of rats with striatal lesions: the relevance of kind and size of the lesion.
    Wolfarth S
    Pharmacol Biochem Behav; 1974; 2(2):181-6. PubMed ID: 4597891
    [No Abstract]   [Full Text] [Related]  

  • 91. Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine.
    Janssen PA; Niemegeers CJ; Schellekens KH; Dresse A; Lenaerts FM; Pinchard A; Schaper WK; van Nueten JM; Verbruggen FJ
    Arzneimittelforschung; 1968 Mar; 18(3):261-79. PubMed ID: 4386815
    [No Abstract]   [Full Text] [Related]  

  • 92. Does a true qualitative difference exist in the mode of action of neuroleptics and thymanaleptics on catecholamine neuron systems.
    Moller Nielsen I
    Mod Probl Pharmacopsychiatry; 1970; 5():68-70. PubMed ID: 5527172
    [No Abstract]   [Full Text] [Related]  

  • 93. The effects of amphetamine, imipramine and ICI 58,834 (Vivalan), a potential antidepressant, on unconditioned behaviour in rats.
    Cox T; Tye N
    Psychopharmacologia; 1975; 40(4):297-304. PubMed ID: 1144643
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Effect of thymoleptics on acid production of the stomach. Preliminary report].
    Fischbach R
    Arzneimittelforschung; 1969 Oct; 19(10):1640-2. PubMed ID: 5395361
    [No Abstract]   [Full Text] [Related]  

  • 95. [Effect of psychotropic substances on neurophysiological parameters in experimental animals].
    Stille G
    Arzneimittelforschung; 1974 Jul; 24(7):1051-7. PubMed ID: 4408054
    [No Abstract]   [Full Text] [Related]  

  • 96. Prolonged neuroleptic effect of alpha-flupenthixol decanoate in oil.
    Nymark M; Franck KF; Pedersen V; Boeck V; Nielsen IM
    Acta Pharmacol Toxicol (Copenh); 1973; 33(5):363-76. PubMed ID: 4801082
    [No Abstract]   [Full Text] [Related]  

  • 97. Analysis of the difference in the behavioral effects of apomorphine in C57BL/6 and DBA/2 mice.
    Vetulani J; Sansone M; Oliverio A
    Pharmacol Biochem Behav; 1982 Nov; 17(5):967-71. PubMed ID: 6891071
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
    Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
    Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Prolactin levels and amphetamine-induced behavioural changes following fluphenazine decanoate administration.
    Merali Z
    Prog Neuropsychopharmacol; 1981; 5(5-6):603-7. PubMed ID: 7339653
    [No Abstract]   [Full Text] [Related]  

  • 100. Effects of SCH 23390 and sulpiride on the behaviors evoked by amphetamine and apomorphine in adult cats.
    Motles E; Gomez A; Tetas M; Gonzalez M
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 Nov; 17(6):1005-22. PubMed ID: 8278595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.